Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 6, Issue 5 , Pages 425-428, September 2010

Web-based application to project the burden of Alzheimer's disease

Department of Biostatistics, Johns Hopkins University, Baltimore, MD, USA

published online 06 August 2010.

Abstract 

Background

Health care planning and research would benefit from tools that enable researchers to project the future burden of Alzheimer's disease (AD) and evaluate the effect of potential interventions.

Methods

We created a web-based application of the AD prevalence model developed by Brookmeyer et al (Am J Public Health 1998;88:1337–42; Alzheimers Dement 2007;3:186–91). The user defines the disease parameters and any interventions that may either reduce risk or slow disease progression. We expanded the parameters to include the cost and weights for disability-adjusted life years.

Application

The secure, web-based application generates detailed AD projections for each calendar year to 2050, and allows users to create personal accounts for them to save, retrieve, and modify the input parameters. The flexibility of the application is illustrated with a forecast for the state of Maryland, USA.

Conclusions

The application generates AD burden projections, costs, and disability-adjusted life years, along with changes associated with potential interventions.

Keywords: Forecasting, Disease burden, Multi-stage disease model, Web-tool, Costs, Preventative therapy, Disability-adjusted life years (DALYs)

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Conflict of interest: H Michael Arrighi was an employee of and owns stock in Elan and is currently an employee of JANSSEN Alzheimer Immunotherapy Research & Development, LLC.

PII: S1552-5260(10)00041-5

doi:10.1016/j.jalz.2010.01.014

Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 6, Issue 5 , Pages 425-428, September 2010